Co-Diagnostics Inc expected to post a loss of $3.75 a share - Earnings Preview

Co-diagnostics

Co-diagnostics

CODX

0.00

  • Co-Diagnostics Inc CODX.OQ CODX.O is expected to show a rise in quarterly revenue when it reports results on May 14 for the period ending March 31 2026

  • The Salt Lake City Utah-based company is expected to report a 225.2% increase in revenue to $163.5 thousand from $50.28 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Co-Diagnostics Inc is for a loss of $3.75 per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated May 12 at 20:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.